Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Cabozantinib
Rectum Malignant Melanoma
National Cancer Institute (NCI)P2CCC (53)
Cabozantinib
Kidney Wilms Tumor
National Cancer Institute (NCI)P2CCC (53)
Cabozantinib
Central Nervous System Cancer
National Cancer Institute (NCI)P2CCC (53)
Cabozantinib
Rhabdomyosarcoma
National Cancer Institute (NCI)P2CCC (53)
Cabozantinib
Soft Tissue Sarcoma
National Cancer Institute (NCI)P2CCC (53)
Cabozantinib
Cancer Or Benign Tumor
National Cancer Institute (NCI)P2CCC (53)
Cabozantinib
Hypopharyngeal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Cabozantinib
Laryngeal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Cabozantinib
Bladder Urachal Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Cabozantinib
Urethra Clear Cell Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Cabozantinib
Vaginal Melanoma
National Cancer Institute (NCI)P2CCC (53)
Cabozantinib
Vulvar Melanoma
National Cancer Institute (NCI)P2CCC (53)
Calaspargase Pegol
Down Syndrome
National Cancer Institute (NCI)P2CCC (53)
Capecitabine
Anal Canal Squamous Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Capecitabine
Anal Margin Squamous Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Capecitabine
HIV Infectious Disease
National Cancer Institute (NCI)P2CCC (53)
Capecitabine
Squamous Cell Carcinoma Of Rectum
National Cancer Institute (NCI)P2CCC (53)
Capivasertib
Urinary Bladder Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Capivasertib
Cervical Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Capivasertib
Colon Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Capivasertib
Endometrial Mixed Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Capivasertib
Endometrial Serous Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Capivasertib
Endometrial Undifferentiated Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Capivasertib
Endometrioid Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Capivasertib
Carcinoma Of Esophagus
National Cancer Institute (NCI)P2CCC (53)
Showing 1126 to 1150 of 3,272 assets
PreviousPage 46 of 131Next